JW (Cayman) Therapeutics Co. Ltd. reported unaudited consolidated earnings results for the Six months ended June 30, 2021. For the period, the company reported operating loss of RMB 333,578,000 compared to RMB 158,311,000 a year ago. Loss for the period was RMB 280,695,000 compared to RMB 650,029,000 a year ago. Basic loss per share was RMB 0.71 compared to RMB 9.96 a year ago.